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INTRODUCTION 
World population is a major problem which is more than 6.3 
billion people and with 26 children being born every second. The 
population of India has been growing quite rapidly. By 2050, the Indian 
population may reach 1.5 billion
1
. 
 For healthy spacing of pregnancy the birth-birth interval should be 
at least 36 months/ 3 years between children. 
Closely spaced pregnancies are associated with the following 
outcomes
2
: 
 BABY 
 Preterm births 
 Low birth weight 
 Neonatal death 
 
 WOMEN 
 Anaemia  
 Abortion 
 PROM 
 Maternal mortality 
2 
 
            Births  occurring within 1 year of last child birth in India is 27%. 
34% occur between 1
st
 & 3
rd
 year. Nearly 61% of births
2
 occur before the 
recommended period of 3 years.  
                    
 
 
 Returning for postpartum contraception after delivery poses 
multiple challenges to women. Hence postpartum IUCD insertion gives 
opportunities for women to obtain a very effective & long term reversible 
contraception method. Increase in institutional deliveries under JSY 
(Janani Suraksha Yojana)  scheme favours this service.  
65% 
24% 
10% 
1% 
 UNMET NEED 65%
USING METHOD 24%
DESIRE BIRTH 10%
INFECUND 1%
3 
 
Reproductive health & medical grounds are now the other 
considerations for birth control. It is reckoned that a woman below 20 
years is not physically grown to produce the child.  If she does reproduce, 
she becomes a high risk case during pregnancy and labour and is likely to 
deliver a low birth weight new born. Spacing birth 3 years apart is 
considered beneficial for both mother and child. Birth control is thus seen 
as a woman’s health measure. 
 
 A multiparous woman from a low income group generally suffers 
from malnutrition and is also pre dispose to prolapse, stress incontinence, 
chronic cervicitis  and cancer cervix
1
. The spacing of child birth and 
limiting the number of pregnancies are strongly desirable for this reason.  
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AIM OF STUDY 
•  To assess the acceptability of postpartum intrauterine copper-T 
insertion.  
•  Follow up  of 300 cases (150 in post placental group and 150 in 
intra caesarean group)   at 6 weeks,3 months,6 months  to evaluate 
PPIUCD in terms of 
                       -expulsion rate 
                       -rate of removal 
                       -continuation rate 
                       -complications  
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REVIEW OF LITERATURE 
CONTRACEPTION 
 A method or a system which allows intercourse and yet prevents 
conception is called a contraceptive method
1
. This contraception may be 
temporary when the effect of preventing pregnancy lasts while the couple 
uses the method but the fertility returns immediately or within a few 
months of its discontinuation. The permanent contraceptive methods are 
surgical: tubectomy in a woman and vasectomy in a man. 
 The choice of contraception depends upon the following: 
 Availability, cost. 
 Age and parity of the couple. 
 Reliability (failure rate). 
 Side effects, contraindications to a particular method 
 Advantages and disadvantages 
 Requirement of follow-up 
 Counselling and allowing the couple to make a choice.  
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Methods of contraception: 
1. Natural methods:  
 Abstinence during the fertile phase 
 Withdrawal (coitus interruptus) 
 Breastfeeding 
 
2. Barrier contraceptives: 
 Use of condoms by male 
 Use of spermicidal agents 
 Use of diaphragm, or the cervical cap in the vagina, 
use of female condom. 
 Use of hormones which alter the cervical mucus and 
prevent entry of sperms into the cervical canal. 
 
3. Intrauterine contraceptive devices (IUCDs) 
4. Suppression of spermatogenesis 
5. Suppression of ovulation with hormones-hormonal contraceptives 
7 
 
6. Interceptive agents (postcoital contraception)  
7. Immunological methods 
8. Surgical sterilization 
 
Failure rate of any contraceptive method is described in terms of 
pregnancy rate per 100 woman years (Pearl index).  
Contraceptive methods should be effective, long-acting, safe, 
coital-independent and reversible. Besides, they should be available and 
affordable with minimal side effects. (IUCD fits into this criteria)  
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HISTORICAL REVIEW 
2500 years ago Hippocrates is credited with using a hollow lead 
tube to insert pessaries or other objects into human uterus. 
Cervicouterine stem pessaries were used from late nineteenth 
century. They were made from ivory, glass, diamond studded platinum. 
They were shaped like collar, stud or had V shaped flexible wings 
inserted into the lower uterine cavity. Dr.Ritcher of Braslaw described the 
first complete intrauterine device made specifically for contraception, 
which was a ring made of silkworm gut. Later, silver wire wound around 
silkworm was introduced by Grafenburg and later version were made of 
German silver, an alloy which contains copper. 
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Now, made of coiled stainless steel, this design is still one of most 
widely used in China.  
 Many of early devices were used as abortifacients and 
contraceptives. The acceptance of IUCDs was achieved only in 
1962 at International Conference of IUDs in New York city. Jack 
Lippes developed Lippes Loop and presented it to this conference 
and became the standard and now copper IUCD became popular. 
 Worldwide intrauterine devices are the most commonly used form 
of reversible contraception with more than 160 million currently 
using this method
3
.  
 Acceptability is higher in women who receive IUCD insertion in 
the postpartum period. Mohamed et al
4
. showed that women who 
received PPIUCDs  after delivery  were 10 times more likely to 
have    IUCDs inserted   than women willing for  copper T 
insertion after involution of uterus. 
 In a study in Egypt5 out of 3,541 clients, 1,024 (28.9%) accepted 
PPIUCD .Acceptance rate was approximately 26.4% and 31.8%, 
respectively, when counselled in antenatal and post partum period. 
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 PPIUCD was recommended more than 4 decades ago 
(ROSENFIELD A,VARAKAMIN S)
6
 in 1967 but uptake is slow 
except in China and Mexico where it is widely used. The MOH in 
conjunction with non government organizations e.g. USAID, 
JHPEIGO, FHI are involved in training of PPIUCD to enhance 
uptake of this method.  
 Post partum IUCD has been proven to be both safe and feasible7. 
 Outcomes of immediate post placental insertion like increase in 
post partum blood loss which was thought to be significant earlier 
has been disputed by studies showing minimal or no increase in 
blood loss
8
. 
 IUCD is the safe method that does not increase the incidence of 
STD acquisition.(MORRISON CS)
9
 
 Cochrane database 2004 study on early post placental insertion of 
IUCD showed it to be safe, effective and there was no bleeding, 
infection nor perforation
10
 .The main disadvantage was increased 
expulsion, and it was 12.3% at 1 year with the copper T. 
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  Taskin et al11 compared post placental with interval copper –T 
insertion showed that  no statistically significant difference was 
found between the groups for uterine perforation and infection. 
Pregnancy rates at 1 year for all groups were 3.1%. 
 A prospective cohort study12 on Immediate post placental IUD 
insertion at caesarean delivery  conducted on 90 patients showed 
that 48% women returned for 6-week follow-up visits, and no 
expulsions were recorded. 47% women were reached for phone 
follow-up at 6 months postpartum. Study showed that immediate 
post placental IUD insertion at the time of caesarean delivery is 
safe and acceptable. 
  A recent pilot study13 conducted on intra caesarean placement of 
the copper T-380A, in women undergoing elective caesarean 
delivery. 
Study was done to analyse the status of the tail strings and the 
original tail strings were visible at 6 weeks.  It was concluded that 
successful intra caesarean placement of Copper T-380A IUDs 
through incision at the time of caesarean birth is possible. 
 
13 
 
  Post-placental insertion appears to be a convenient approach  with 
no  increase in the incidence of  endometritis or excessive 
bleeding
14
. 
 A women’s Health study15 – showed the only pelvic infection that 
has been unequivocally related to IUCD use is actinomycosis and 
that too occurred in women who had multiple sexual partner. 
 Comparative study  16   of two techniques used (manual insertion by 
hand and forceps respectively) in immediate post placental 
insertion of the Copper T-380A IUD showed no differences  
(p > 0.05). No uterine perforation, infection or pregnancy occurred. 
 Study on Acceptability, Uptake and Safety of Intra-Operative 
IUCD Placement at Kenyatta National Hospital and Pumwani 
Maternity Hospital
17
 showed the  acceptance rate of IUCD 
insertion stood at 36.3% .Uptake of IUCD was 91% with 9% of the 
mothers accepting the method but IUCD was not inserted. Out of 
the 71 parturients 66(93%) had their strings visualized and 5 (7%) 
had no string protruding at the external os. Imaging done showed 
fundal placement of the IUCD in 3 patients who had sub involution 
of  uterus, 1 was displaced IUCD and 1 had expelled (1.4%). 
14 
 
 Some researchers have tried suspension of IUCD with chromic 
sutures to reduce expulsion rates. This however was seen to have 
no impact on clinical outcomes
18,19,20
. 
 The type of IUCD models studied earlier is out dated. Copper 
bearing IUCDs generally have low expulsion rates
21
 suggesting the 
popularity of Copper-T 380 A for postpartum insertion.  
 Studies have shown that uterine perforation following post 
placental IUCD is almost unheard with most studies showing no 
complication of perforation
22,23,24
. 
 Multiple studies have shown no increased risk of uterine or cervix 
malignancy in IUCD users
25,26
. 
 Copper T 380A and hormone releasing IUCDs provides 
contraceptive protection similar to that achieved by tubal 
sterilisation
27
 with a pregnancy rate of 2%.Pregnancy rates of post 
placental insertion has shown a rate varying from 0-2%.  
 Women attempting pregnancy after IUCD removal conceive at 
similar rate as those discontinuing other contraceptives with 
approximately 80% achieving in 1
st
 year
28
. 
15 
 
   Ory  HW, for Women’s Health study15 , showed there is 80%-
90%  reduction in the risk of ectopic pregnancy due to higher dose 
of  copperT380A. 
 The Oxford study Vessey M, Doll R, Peto R, et al , Found that           
women gave birth just as promptly after IUCD removal as they did           
after discontinuing use of the diaphragm. 
 A Cochrane data base23 – Grimes DA, Lopez LM et al 2006, The          
discontinuation for pain and bleeding is higher with copper IUCD.        
The worsened periods often occur with the first few menses and         
they are treated with NSAID’S. 
 Rosenberg MJ, Waugh MS, A prospective evaluation of 
discontinuation between oral contraception and IUCD 1998
29
, 
The continuation rate at the end of 1 year for Copper T 380A- 
78%,OCP- 50%. 
 French R, Van Vliet H, Cowan F et al 2004- A Cochrane 
Database
30 
of pregnancy rates. The pregnancy rates at end of  
1 year, Copper T 380 -  0.6-0.8 and LNG IUS- 0.1.per 100 woman 
years. 
 
16 
 
 In a longitudinal international study which was conducted by the          
WHO
31
, where the average annual pregnancy rate was 0.4%, and 
the  average cumulative pregnancy rate was 2.2% at the end of 12 
years  of use of CuT 380A, which is very similar to that of tubal 
sterilization.  (United Nations Development Programme et al. 
1997). 
 
IUCD 
This was first introduced by Grafenberg   in 1909. It is an effective, 
reversible and long term method of contraception, which does not require 
replacement for long periods and does not interfere with sexual activity. 
Medicated devices which contain copper, progesterone hormone and 
other pharmacologic agents  have  been introduced. Each device has a 
nylon thread attached to its lower end and this thread protrudes through 
the cervical canal into the vagina ,where it can be felt by the patient 
herself  and by the doctor, and can be removed by pulling it with the 
forceps. 
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Classification: 
 Biologically inert devices: 
                                          Lippes loop 
Saf-T-Coil       
 Inert IUDs, mostly Lippes loops are still commonly used in China, 
Indonesia, Pakistan and Turkey (WHO, 1997)
32
. The Lippes loop made of 
polyethylene, impregnated with barium sulphate for making it 
radiopaque, is the most widely used inert IUD outside China. The other 
widely used IUDs are the inert single-coil ring and double-coil ring 
(Mahua ring), both made of stainless steel, they are used only in China; 
of the two, the single-coil ring is more popular. The Grafenberg ring, first 
introduced in Germany,  and the Ota ring, first introduced in Japan and 
widely used over there, have become outmoded now.                                         
They can be left in situ for several years because they cause no side 
effects. Because of litigations following complications, these have been 
withdrawn and stopped being marketed.  
18 
 
   
LIPPES LOOP 
 Copper carrying devices : 
1. Copper 7 (Gravigard). This type of IUD is made of polypropylene 
impregnated with barium sulphate for radiopacity. It has horizontal 
bar of 26mm and a vertical bar of 35.9mm on which a copper wire 
with 200mm
2
 exposed surface area  is wrapped. It has got 
polypropylene transcervical thread tails. Its USFDA-approved 
effective life is 3 years. It was used mostly in Australia, Canada, 
19 
 
Europe, Mexico and UK. In most countries, it has been replaced by 
other medicated devices. 
2. Copper T 200 (Gynae T). This device is made of polypropylene 
impregnated with barium sulphate and carries 120mg of 0.25mm 
diameter copper wire wound round the vertical limb. The device 
was the first medicated IUD tested for use, and has been widely 
tried and used throughout the world. The copper portion has an 
exposed surface area of 200 mm
2
. Its USFDA-approved effective 
life is 4 years. 
3.  Multiload Copper 250 (ML Cu 250) and Multiload copper 375 
(ML Cu 375). These are copper-releasing devices made of 
polypropylene with 250 or 375 mm
2
 of exposed copper in the form 
of wire, wrapped around the vertical shaft. The arms are flexible 
plastic-serrated fins that hold the device in place without stretching 
the uterine cavity. The copper wire around the shaft makes this 
portion radiopaque but the arms are radiotranslucent. The 
Multiload Cu 250 has a recommended life span of 3 years and the 
Multiload Cu 375, of 5 years. 
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4.  Copper T 380 Copper T 380A (Paraguard) is being used under the 
government program. It is a T-shaped polyethylene device 
containing copper wire of surface area 380mm
2 
wrapped on its arm 
& stem. It remains radio opaque as it contains Barium Sulphate on 
polyethylene frame. Its length is 3.6 cm & 3.2 cm. 
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A 3mm ball is present at the base of the stem. It acts to reduce the 
risk of cervical perforation with expulsion. A clear white 
polyethylene monofilament string is knotted through this ball for 
easy removal. 
It is approved by FDA up to 10 years but is effective at least for 12 
years. It is more than 99% effective and there are 0.6 – 0.8 
pregnancies/100 women in first year. 
5. Copper T 220 (CuT 220C). This device is an experimental 
modified version of the Cu T200. It was developed by the 
Population Council and has seven copper sleeves, two on the 
22 
 
transverse arm and five on the stem with a total exposed surface of 
220 mm
2 
. It has an estimated effective life of 3 years. 
6. Nova Cu T200 (Nova T). This device has been introduced 
commercially since 1979. It is modified Cu T200 with a silver core 
added in the copper wire around the stem; 200 mm
2 
of copper is 
exposed to the surface. The silver core increases its effective life to 
5 years. 
The copper devices are more expensive than inert devices but are 
reported to exert a better contraceptive effect; with fewer side effects 
.They have effective life of about 3 – 5 years. It is estimated that about 50 
mcg of copper is eluted daily in the uterus .Copper T 380A known as 
Paraguard  has a life span of 10 years .Nova T has silver added to copper 
wire thereby increasing its lifespan to 5 years.  
 Progestasert and levonova: 
 Progestasert is a T shaped device carrying 38 mg of progesterone in 
silicon oil reservoir in the vertical stem .It releases 65mcg of hormone per 
day. The hormone released in the uterus forms a thick plug of mucus at 
the cervical os which prevents sperm penetration. It is expensive and 
requires yearly replacement.  
23 
 
                    A new device Levonova contains 60 mcg of levonorgesterol 
and releases the hormone in very low doses (20 mcg/day). It is longer 
acting (5 years) and has low pregnancy rate of 0- 3 per 100 woman years. 
                  Mirena contains 52 mcg levonorgesterol, eluting 20 mcg 
daily. It can be retained for 5 years with a failure rate of 0.1 to 0.4 per 
100 woman years. 
 
                  Frameless IUCD  contains several copper cylinders tied 
together on a string and is anchored 1 cm deep into fundus
1
.  
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MODE OF ACTION 
            The copper stimulates a cytotoxic reaction which is spermicidal. 
Several  mechanisms are responsible for contraceptive effect of an IUCD. 
 The presence of a foreign body in uterine cavity renders migration 
of spermatozoa difficult. 
 A foreign body within uterus provokes uterine contractility 
through prostaglandin release and increases tubal peristalsis so that 
fertilised egg is propelled down the fallopian tube more rapidly 
than in normal and it reaches the uterine cavity before  the 
development  of chorionic villi and thus is unable to implant.  
 The device in situ causes leucocytic infiltration in the 
endometrium. The  macrophages  engulf the fertilised egg if it 
enters the endometrial tissue. 
 Copper T elutes copper which brings about certain enzymatic and 
metabolic changes in the endometrial tissue. 
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Effectiveness: 
 The copper T 380A is > 99% effective. This effectiveness 
increases when expulsion rates are increased. During the 1
st
 year of use 
there are about 0.6 – 0.8 pregnancies / 100 women1. 
 
USES OF IUCD IN GENERAL 
 As a contraceptive 
  Postcoital  contraception. 
 Following excision of uterine septum, Asherman’s syndrome. 
 Hormone IUCD –Mirena in menorrhagia and dysmenorrhea 
 
ADVANTAGES OF PPIUCD 
 Assurance for a reliable birth spacing method before leaving 
hospital. 
 Decreased awareness of initial side effects (bleeding and 
cramping). 
26 
 
 Effective long term contraception. 
 Does not interfere with sexual functions. 
 Saves time. 
 Resumes fertility immediately on removal. 
 Perforation has not been reported because of thickness of uterine 
wall postpartum. 
 Coital independent. 
 One time insertion gives a continuous protection for a longer 
period. 
 There is no user failure 
 There is no evidence of reduced fertility. About 75%  of women 
conceive within 6 months of its removal and almost 90% conceive 
within a year. 
 There is no systemic  ill effects unlike oral contraceptive pills. 
 No adverse effect on lactation is observed. 
Copper T is inserted free of cost in government hospitals in India. . 
27 
 
LIMITATIONS 
 Spontaneous expulsion rates vary in range of 10-14%.It is also 
viewed as retention rate of 90%. 
Proper placement of IUCD reduces the expulsion rate. This can 
reduce expulsion rates to 2-5%. 
 Bleeding or spotting between periods or cramps occur in first 3 
months, there after lessens. 
 Insertion as well as removal is provider dependent. 
 
SIDE EFFECTS 
 Bleeding and cramping pain occurs but usually subsides2; they are 
often obscured in the postpartum period. 
 There appears no significant risk on genital tract infection in 
postpartum insertion. 
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Early complications: 
 Expulsion 
 Spotting,menorrhagia 
 Dysmenorrhea 
 Vaginal infection 
 Perforation. 
 Late complications: 
 Pelvic inflammatory disease 
 Pregnancy 
 Perforation 
 Menorrhagia 
 Dysmenorrhea 
 
There is no evidence that the device predisposes to cervical or 
endometrial cancer.                 
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CONTRA INDICATIONS 
 Lower genital tract infection 
 Severe anaemia 
 Pelvic inflammatory disease 
 Menorrhagia, Dysmenorrhoea if copper T is used 
 Uncontrolled diabetes – because of slight increase in pelvic 
infection 
 Heart Diseases - risk of infection  
 
 MANAGEMENT OF IUCD RELATED SIDE EFFECTS 
AND COMPLICATIONS 
 Spotting /bleeding in the first three months 
      Rule out uterine pregnancy or ectopic pregnancy, infection and 
IUCD expulsion. Spotting or slight bleeding is common during the first 3 
to 6 months of using a copper bearing IUCD. It is not harmful and 
usually decreases over time. 
30 
 
Changes in menstrual bleeding patterns like increase in amount 
,duration and cramping are the most common side effects of copper 
IUCDs .The symptoms usually resolves spontaneously. 
If the client desires treatment, a short course of non steroidal anti-
inflammatory drugs e.g. ibuprofen may be given during the days of 
bleeding. Remind the client that menstrual changes will resolve after first 
few months. 
If the women presents with persistent spotting and bleeding 
exclude gynaecologic problems as indicated by history and physical 
assessment.  If gynaecological problem is identified ,treat the condition. 
If no gynaecological problem is found and she finds the bleeding 
unacceptable ,remove the IUCD and help her choose another method. 
 Cramping pain 
Rule out pregnancy ,ectopic ,infection and IUCD expulsion .If 
none of the above ,offer non steroidal anti-inflammatory drugs 
immediately before and during menstruation to help relieve the 
discomfort. 
If the cramping is stronger than usual it might be due to impending 
expulsion .Expulsion of an IUCD is most common in the first 3 months 
31 
 
after insertion. Other symptoms associated with expulsion include 
irregular bleeding, pain during intercourse, unusual vaginal discharge, 
post coital bleeding and delayed menses. 
 If strings not seen 
At the first post insertion visit, the strings may not have descended 
yet. 
If the client is otherwise well ,has experienced no cramping or 
bleeding and has not felt the IUCD or observed it to have been expelled, 
do a speculum examination to locate the strings. 
If the strings are not located in cervical canal, an ultrasound is done 
to confirm that the IUCD is intrauterine .If found to be in position, 
reassure and  explain that IUCD is protecting her from pregnancy and to 
review if there are any complaints and ask her to come for follow up. If 
the IUCD is located inside uterus, but patient wants removal due to her 
concern of missing strings, counsel about contraceptive benefits. If still 
insists on removal it is removed by a trained provider. 
If the IUCD is not seen inside or outside the uterus, complete 
expulsion must have occurred and offer the client to replace the IUCD. If 
32 
 
the client is willing, then reinsertion done. If not willing, then ask her to 
choose any other contraceptive method. 
If IUCD is found outside the uterus, manage as per uterine 
perforation. 
 Expulsion 
    If complete expulsion is confirmed, IUCD is replaced if desired or 
patient is counselled on other contraceptive methods .If in case of partial 
expulsion, remove the IUCD and decide according to the patient’s desire. 
 Pregnancy 
Rule out ectopic pregnancy. The overall risk of ectopic pregnancy 
is very low.1 in 1000 over 5 years. 
Explain to the client that she is at increased risk of first and second 
trimester miscarriage and of preterm delivery if the IUCD is left in place. 
Counsel the client that removal slightly reduces these risks, although the 
procedure itself can itself cause a small risk of miscarriage. 
If the client does not want to continue the pregnancy, counsel her 
accordingly. 
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If the client wishes to continue pregnancy, inform her about the 
increased risk of first and second trimester abortion and preterm delivery. 
Advice her to return immediately if she has heavy bleeding, cramping 
pain , abnormal vaginal discharge or fever. 
If the IUCD strings are visible and can be retrieved safely from the 
cervical canal, then advice the client that it is best to remove the IUCD. 
If the IUCD is to be removed, remove it by pulling on the strings 
gently. Explain to the client that she should return in case of bleeding 
,pain or fever .If she chooses to keep the IUCD, advice her accordingly. 
If the IUCD strings are not visible ,and cannot be retrieved safely 
from the cervical canal, perform an ultrasound and if it is found inside the 
uterus ,explain the risks to the client and monitor closely. 
 Infection 
     It is generally related to concurrent Gonorrhea or Chlamydia 
infection.  
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Symptoms include: 
 Vaginal discharge 
 Pain with intercourse 
 Abdominal pain 
 Fever 
                 Treat in the presence of uterine or adnexal tenderness or oral 
temperature more than 38.3C, abnormal cervical or vaginal discharge, 
elevated ESR, lab documentation of gonorrheal or chlamydial infection. 
Treat using appropriate antibiotics.If infection does not improve within 
72 hours ,remove the IUCD and continue antibiotics and monitor closely. 
Provide dual method use for sexually transmitted infection including 
counselling about condom use. 
There is no need to remove the IUCD if the client wishes to 
continue it. Removing the IUCD provides no additional benefit once the 
infection is treated with appropriate antibiotics. 
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 Perforation: 
            This is very rare. If  it occurs stop insertion immediately. If the 
IUCD has already been placed, remove it by pulling the string. 
 The signs and symptoms of perforation are feeling of sudden give 
way, pain, tachycardia, receding of threads. 
 Monitor BP, pulse, pain, guarding and rigidity. Start an iv line and 
monitor for any intra abdominal bleeding. 
 Monitor vitals every 10 minutes for the first 1 hour, if stable 
continue every hour for the 1
st
 4 hours, then four hours once for 
24 hours. 
 If there is change in vitals, then decide on surgical intervention.  
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TIMING OF INSERTION 
 Post placental2: within 10 minutes following expulsion of placenta 
in vaginal delivery. 
 Intra caesarean: during caesarean delivery before closing uterine 
incision. 
 Immediate postpartum: Within 48 hours of delivery after post 
placental period. 
 Post abortion: following abortion. 
 Interval: after 6 weeks postpartum.  
       Insertion  between  48 hours to 6 weeks is not recommended 
because of increase in the chance of infection and expulsion. 
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POSTPARTUM IUCD INSERTION 
This was introduced in mid sixties in U.S. 
Studies show that prevention of unplanned pregnancies could 
prevent 20-35% of maternal deaths. The Copper T 380 A has been 
approved for postpartum insertion. 
Counselling for PPIUCD services should take place in antenatal 
period, or in early labour or immediate postpartum. Informed consent 
should be obtained prior to insertion. It should not be taken in active 
stage  of labour.  
 
 
                                        
                                        
 
 
 
  
 
 
MATERIALS AND 
METHODS 
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MATERIALS AND METHOD 
This study was conducted in R.S.R.M Lying in Hospital, 
Royapuram,   Chennai from January to September 2014. 
TYPE OF STUDY –  Prospective study. 
METHODOLOGY –  
Contraceptive counselling was given to 932 eligible antenatal 
women admitted in labour ward  from January to March . Women who 
accepted the PPIUCD  after normal vaginal delivery and after caesarean 
section were inserted with the device after obtaining written informed 
consent. The acceptance rate of PPIUCD and the percentage of actual 
insertions were recorded .  Among those inserted, 300 cases – 150 cases 
in post placental group and 150 cases in intra caesarean group were 
followed up at 6 weeks,3 months and 6 months to evaluate in terms of 
expulsion, removal and continuation. 
The chi square test was used to evaluate the data. 
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INCLUSION CRITERIA 
  Women admitted in labour room who were eligible for PPIUCD 
insertion. 
 Women who were willing for PPIUCD insertion and willing to 
return for follow up. 
EXCLUSION CRITERIA 
 Those women who were not willing for PPIUCD insertion. 
 Fever during labour. 
 Premature rupture of membranes for more than 18 hours. 
 Chorioamnionitis. 
 Active lower genital tract infections. 
 AIDS. 
 Uterine anomalies. 
 Uterine abnormalities like myoma uterus. 
 Manual removal of placenta. 
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 Post partum haemorrhage-uterine atony,traumatic. 
 Anaemic women. 
 Heart disease complicating pregnancy. 
 
MEDICAL ELIGIBILITY CRITERIA 
It describes IUCD use for women under specific medical 
conditions .The reproductive rights of the individual must be considered. 
It is essential that the provider has to screen the women based on the 
MEC in order to provide the quality care in IUCD services. 
It has 4 categories
33
:  
 CATEGORY 1 : no restriction for use 
 Immediate post placental 
 During caesarean section 
 Immediate postpartum < 48 hours 
 > 6 weeks postpartum 
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 Parity 1 or more 
 Metrorrhagia without heavy bleeding 
 Risk factors for cardiac disease 
 Hypertensive disorders, diabetes, thyroid. 
 CATEGORY 2 : advantages of using this method outweighs 
theoretical or proven risk. 
 Bleeding more than usual 
 Nulliparous woman 
 Clinically well HIV infected women 
 Symptomatic AIDS women, on antiretroviral 
therapy 
 Immediately following a second-trimester abortion 
either  spontaneous or induced with no evidence of 
infection. 
 Anaemic women, as copper-bearing IUCDs are 
associated with increased menstrual blood loss. 
 Women with 1st and 2nd degree uterine prolapse 
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 Rectovaginal fistula 
 Complicated valvular heart disease e.g., artificial 
shunts, rheumatic heart disease. 
 
 CATEGORY 3 : generally do not use 
 High risk for gonococcal and chlamydial 
infection 
 Ovarian cancer  
 Benign trophoblastic disease 
 HIV not on anti retroviral therapy 
 
 CATEGORY 4 : do not use 
 Unexplained vaginal bleeding 
 Current gonorrhoea or chamydial infection 
 Pelvic tuberculosis 
 Genital tract cancer 
 Distorted uterine cavity 
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MATERIALS REQUIRED 
 Sims or vaginal retractor 
 Ring forceps or sponge holding forceps 
 Kellys placental forceps 
 Cotton swabs  
 Betadine 
 Sterile gloves 
 Copper T 380A,in sterile package  
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ANATOMY OF POSTPARTUM UTERUS 
Immediately after placental expulsion the fundus of uterus is 
approximately 20 wks size. It weighs about 1 kg. The anterior and 
posterior walls of uterine body lie close to each other. The walls are  
4-5 cms thick and soft. The lower uterine segment is stretched and adds 
to mobility of uterus. 
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The difference   between the heavy and thickened body of the 
uterus and the lower uterine segment contributes to the extreme curvature 
that can be noted on bimanual examination
2
. 
 
TYPES OF INSERTION 
Post placental – insertion within 10 minutes of placental delivery 
          Insertion can be done either by forceps or manually. 
 Forceps – kellys placental forceps is used. 
  Manual insertion – this requires long gloves for protection of 
both provider and woman. 
Intra casaerean – insertion is done manually before uterine closure. 
The IUCD is held between middle and index finger and inserted in   
uterine fundus. Strings should not be pushed into cervical canal for 2 
reasons. 
 To prevent displacement of IUCD from uterine fundus 
 To prevent uterine cavity contamination by vaginal flora. 
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MANUAL INSERTION 
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TECHIQUE OF INSERTION 
After active management of third stage of labour and verifying that 
uterus has contracted, inspect the genital area for lacerations, repair can 
be done after insertion of PPIUCD. 
 With sterile gloves on, cervix is visualised by depressing posterior 
vaginal wall with Sims speculum.  
 Cervix and vagina is cleaned with antiseptic solution twice. 
 The anterior lip of cervix is then grasped using ring forceps. 
 IUCD is gently grasped with kellys forceps with no-touch 
technique. 
 The IUCD held in kellys forceps is carefully passed into lower 
uterine cavity without touching vaginal side walls. 
 Once the lower uterine cavity is entered, the left hand is placed over 
the abdomen and entire uterus is pushed upward. This is done to 
straighten the angle between uterus and vagina. This in turn 
facilitates the instrument to move upwards easily towards uterine 
fundus. 
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 On reaching the uterine fundus a resistance is felt . Kelleys forceps 
has a broad end distally which is less likely to perforate uterine 
fundus.  
 At this point, open and release IUCD. 
 By keeping it open ,the instrument is swept to the right and slowly 
withdrawn following lateral uterine walls. 
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 The uterus is stabilised until the forceps is removed. 
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 Then episiotomy repair is proceeded  
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Insertion between 48 hours after delivery to 6 weeks 
postpartum is not recommended due to increased risks of 
complications. 
 
within 10 
minutes 
of 
placental 
delivery 
within 48 hours 
postpartum 
6 weeks 
postpartum 
Increased chance of 
expulsion and infection. 
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POST INSERTION COUNSELLING 
Following insertion woman must be instructed on 
 Normal postpartum symptoms 
 Side effects of IUCD 
 Breast feeding importance and that it is not affected by PPIUCD. 
 Follow up visits 
 To return anytime if there are warning signs 
This counselling is done the next day after post placental or intra 
caesarean insertion. 
 
Warning signs include 
 
 Foul smelling vaginal discharge 
 Pain associated with fever or chills 
 When in doubt that IUCD has fallen out. 
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PROPER DISPOSAL 
Dispose the waste materials like cotton balls and disposable gloves 
in a leak proof container .  
 
FOLLOW UP VISITS 
Follow up for both post placental and intra caesarean were 
scheduled at 6 weeks, 3 months and 6 months. During each visit any 
problems related to IUCD were asked. A speculum examination is done 
to visualise strings. If strings were not visualised USG was done to 
confirm IUCD in position or expelled. 
According to WHO guidelines atleast 1 postpartum visit at 6 weeks 
is recommended
2
. A routine pelvic examination is not required. If no 
problems encountered with PPIUCD no other follow up is required. 
Removal should be done only at patients request or in cases of 
 Partial expulsion 
 Puerperal sepsis 
 Severe uterine cramping 
 Perforation 
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Postpartum IUCD Reference DEFINITIONS 
 ACCEPTANCE :  
           Number of clients who after counselling agreed to have IUCD 
inserted . 
 ACTUAL INSERTION: 
Number of clients who actually had IUCD  inserted . This excludes 
those who prior accepted and had medical contraindications after 
delivery. 
 EXPULSION: 
When the strings cannot be visualised in the cervical canal and 
confirmed by USG that IUCD is not within or outside uterus. This 
also includes women who report visual expulsion of IUCD. 
 MISSING STRINGS: 
When the strings of IUCD are not visualised despite confirming 
that IUCD is in situ by USG . 
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 PERFORATION: 
When the strings are not visible and  IUCD is diagnosed to be 
outside the uterine cavity by X ray or USG.  
 CONTINUATION: 
The number of women having IUCD in situ after excluding 
expulsion and removal . 
 
 
  
  
 
 
RESULTS AND 
ANALYSIS 
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RESULTS 
Total number of deliveries from January 2014 – March 2014 = 2200. 
TABLE 1 
PARITY 
NORMAL 
LABOUR 
LSCS 
LSCS 
WITH ST 
PS 
P1 655 420 - - 
P2 448 205 314 340 
P3 104 11 38 53 
P4 4 - 1 4 
 
Excluding those willing for sterilisation, 1450 women were 
checked for eligibility. Among them 230 had h/o draining more than 18 
hours,173 had h/o fever,15 had uterine abnormalities,89 were anaemia 
complicating ,5 were HIV infected,6 were heart disease complicating.  
About  932 were eligible for insertion and hence counselling given 
to antenatal women admitted   in labour room and in early labour.368 
women accepted copper t insertion and among them 362 were actually 
inserted. (2 had distorted uterine cavity due to fibroid and 4 had PPH 
after normal delivery) . 
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                        Acceptance rate – 39.4% 
                       Actual insertion rate – 38.8% 
ACCEPTABILITY OF PPIUCD 
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TABLE 2 
 Post placental Intra caesarean Total 
Number 
motivated 
550 382 932 
Number 
accepted 
200 
(36.3%) 
168 
(43.9%) 
368 
Number 
inserted 
196 
(98%) 
166 
(98.8%) 
362 
 
         Among those counselled 36.3% in post placental group and 43.9% 
in intra caesarean  group accepted for PPIUCD insertion. 
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TABLE 3 
PARITY WISE 
Parity Post placental Intra caesarean Total 
P1 157 133 290   
(80.11%) 
P2 36 31 67 
(18.51%) 
P3 5 -- 5 
(1.38%) 
 
Majority of them belong to primiparity (80.11%), multiparity were 
few as they preferred a permanent method of sterilisation. 
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PARITY WISE 
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80.11% belong to primi parity and 18.51%  belong to parity 2 and 
1.38%  belong to parity 3. 
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TABLE 4 
AGEWISE 
         Age group     Post placental  Intra 
caesarean 
     < = 20       64   (32.3%)      41 (25%) 
    21 – 25     106   (53.5%)      96   (58.5%) 
    26 – 30       28    (14.14%)      25   (15.2%) 
     >30       -        2   (1.21%) 
 
Maximum insertion is in age group = 21-25 years. 53.5% in post 
placental group and 58.5% in intra caesarean group. 
Least insertion in age > 30 years. Nil in post placental and 1.21% 
in intra caesarean group 
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AGE WISE 
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TABLE 5 
EDUCATION STATUS 
        Education         Post placental        Intra caesarean 
Illiterate 15 (7.57%) 14 (8.53%) 
Primary education 34 (17.17%) 18 (10.97%) 
Secondary education 97 (48.9%) 94 (57.3%) 
Higher secondary 39   (19.6%) 24 (14.6%) 
Graduate 13   (6.56%) 14   (8.53%) 
 
Majority of acceptors belong to secondary education 48.9% in post 
placental and 57.3% in intra caesarean group. There are few graduates 
because majority of antenatal women coming to our hospital belong to 
low socio economic status.  
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                                                 TABLE - 6 
FOLLOW UP RESULTS 
            Age wise distribution within group 
Age Group 
  
  
Group Total 
Post 
Placental 
Cu-T 
Intra 
Caesarean 
Cu-T   
<= 20 
  
  
  
  
Count 64 41 105 
% within 
Group 42.7% 27.3% 35.0% 
  
21-25 
  
  
  
  
Count 
  
76 86 162 
% within 
Group 
50.7% 57.3% 54.0% 
  
26-30 
  
  
  
  
Count 
10 21 
31 
 
% within 
Group 
6.7% 14% 10.3% 
  
> 30 
  
  
  
Count 0 2 2 
% within 
Group .0% 1.3% .7% 
 
Total 
 
 
 
Count 
 
150 150 300 
            p value-0.009
**
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AGE WISE DISTRIBUTION 
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                                              TABLE  7 
PARITY  GROUP CROSSTABULATION 
PARITY  Group Total 
 
 
Post 
Placental 
Intra 
Caesarean  
P1LI Count 127 121 248 
 % within 
Group 
84.7% 80.7% 82.7% 
P2L2 Count 23 29 52 
 % within 
Group 
15.3% 19.3% 17.3% 
 Count 150 150 300 
 % within 
Group 
100.0% 100.0% 100.0% 
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PARITY   GROUP  
 
 
               
Among the 300 cases followed up 248 cases (82.7%) belonged to 
parity1 and 52 cases(17.3%) belonged to parity 2. 
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TABLE 8 
6 WEEKS FOLLOW UP IN POST PLACENTAL GROUP 
   Post Placental Total 
      Yes      No  
 
Expulsion 
COUNT 10 140 150 
% 6.67% 93.33% 100% 
 
Infection 
COUNT - 150 150 
% - 100% 100% 
 
Failure 
COUNT - 150 150 
% - 100% 100% 
 
Irregular 
Bleeding 
COUNT 2 148 150 
% 1.33% 98.67% 100% 
 
Strings Seen 
COUNT 93 57 150 
% 62% 38% 100% 
 
Removal 
COUNT 2 148 150 
% 1.33% 98.67% 100% 
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6 WEEKS FOLLOW UP IN POST PLACENTAL GROUP 
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FOLLOW UP AT 6 WEEKS IN POSTPLACENTAL 
GROUP 
 
 Total expulsions in study group was 6.67% (10 cases).Among 
them 7 cases were P2L2 and 3 cases were P1L1. 
 Increase in bleeding than usual was major complaint in 2 cases 
(1.33%). 
 Strings were seen in 93 cases (62%). 
 Removal of copper T was done in 2 cases (1.33%).1 case removal  
was done at patient’s request due to increase in bleeding, other in 
parity 2 willing for interval sterilisation.  
 No cases of infection or failure were reported. 
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TABLE 9 
6 WEEKS FOLLOW UP IN INTRACAESAREAN GROUP 
                                     Intracaesarean Total 
Yes No  
Expulsion Count 1 149 150 
% 0.67% 99.33% 100% 
Infection Count - 150 150 
% - 100% 100% 
Failure Count - 150 150 
% - 100% 100% 
Irregular 
Bleeding 
Count 2 148 150 
% 1.33% 98.67% 100% 
Strings Seen Count 81 69 150 
% 54% 46% 100% 
Removal Count - 150 150 
% - 100% 100% 
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6 WEEKS FOLLOW UP IN INTRACAESAREAN GROUP 
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FOLLOW UP AT 6 WEEKS IN INTRACAESAREAN 
GROUP 
 Total expulsions at 6 weeks was 1(0.67%) occurred in parity 2. 
 Irregular bleeding was the complaint in 2 cases (1.33%). 
 Strings were seen in 81 cases (54%). 
 No cases of removal, failure, or infection were reported. 
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TABLE 10 
3 MONTHS FOLLOW UP IN POST PLACENTAL 
GROUP 
                                              Post Placental 
Total 
Yes No 
Expulsion Count 1 137 138 
% 0.72% 99.28% 100% 
Infection Count - 138 138 
% - 100% 100% 
Failure Count - 138 138 
% - 100% 100% 
Irregular 
Bleeding 
Count 6 132 138 
% 4.35% 95.65% 100% 
Strings Seen Count 106 32 138 
% 76.81% 23.19% 100% 
Removal Count 3 135 138 
% 2.17% 97.83% 100% 
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3 MONTHS FOLLOW UP IN POST PLACENTAL 
GROUP 
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FOLLOW UP AT 3 MONTHS IN POSTPLACENTAL 
GROUP 
 Totally 12 cases (8%) were lost to follow up.138 cases returned for 
follow up. 
  Expulsions in this group were 0.72% (1 case). 
 Irregular bleeding was major complaint in 6 cases (4.35%). 
 Strings were seen in 106 cases (76.81%). 
 Removal of copper T was done in 3 cases (2.17%).It was done at 
patient’s request in case of parity 2 who were willing for interval 
sterilisation. 
 No cases of infection or failure were reported. 
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TABLE 11 
3 MONTHS FOLLOW UP IN INTRACAESAREAN 
GROUP 
                                       Intra     caesarean 
Total 
Yes No 
Expulsion Count - 139 139 
% - 100% 100% 
Infection Count - 139 139 
% - 100% 100% 
Failure Count - 139 139 
% - 100% 100% 
Irregular 
Bleeding 
Count 7 132 139 
% 5.04% 94.96% 100% 
Strings 
Seen 
Count 100 39 139 
% 71.94% 28.05% 100% 
Removal Count 5 134 139 
% 3.6% 96.4% 100% 
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3 MONTHS FOLLOW UP IN INTRACAESAREAN 
GROUP 
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FOLLOW UP AT 3 MONTHS IN INTRACAESAREAN 
GROUP 
 Totally 11 cases (7.33%) were lost to follow up.139 cases returned  
for follow up. 
 Irregular bleeding was major complaint in 7 cases (5.04%). 
 Strings were seen in 100 cases (71.94%). 
 Removal of copper T was done in 5 cases(3.6%).It was done at 
patient’s request in 3 cases of parity 2 who were willing for 
interval sterilisation, 2cases due to irregular bleeding complaint. 
 No cases of infection or failure or expulsions were reported. 
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TABLE - 12  
6 MONTHS FOLLOW UP IN POST PLACENTAL 
GROUP 
   Post Placental 
Total 
Yes No 
Expulsion Count - 134 134 
% - 100% 100% 
Infection Count - 134 134 
% - 100% 100% 
Failure Count - 134 134 
% - 100% 100% 
Irregular 
Bleeding 
Count 2 132 134 
% 1.49% 98.51% 100% 
Strings Seen Count 115 19 134 
% 85.82% 14.18% 100% 
Removal Count 2 132 134 
% 1.49% 98.55% 100% 
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6 MONTHS FOLLOW UP IN POST PLACENTAL 
GROUP 
 
 
 
 
 
112 
0 
0 
0 
2 
19 
2 
15 
Expulsion
Infection
Failure
Irregular Bleeding
Strings not Seen
Removal
Lost to Follow up
85 
 
 
FOLLOW UP AT 6 MONTHS IN POSTPLACENTAL 
GROUP 
 Totally 16 cases (10.6%) were lost to follow up.134 cases returned 
for follow up. 
 Irregular bleeding was major complaint in 2 cases (1.49%). 
 Strings were seen in 115 cases (85.82%). 
 Removal of copper T was done in 2 cases (1.49%).It was done in 2 
cases who had similar complaint of bleeding at 3
rd
 month. 
 No cases of infection or failure or expulsions were reported. 
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TABLE 13 
6 MONTHS FOLLOW UP IN INTRACAESAREAN 
GROUP 
   Intracaesarean 
Total 
Yes No 
Expulsion Count - 128 128 
% - 100% 100% 
Infection Count - 128 128 
% - 100% 100% 
Failure Count - 128 128 
% - 100% 100% 
Irregular 
Bleeding 
Count 4 124 128 
% 3.13% 96.88% 100% 
Strings Seen Count 104 24 128 
% 81.25% 18.75% 100% 
Removal Count 3 125 128 
% 2.34% 97.66% 100% 
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6 MONTHS FOLLOW UP IN INTRACAESAREAN 
GROUP 
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FOLLOW UP AT 6 MONTHS IN INTRACAESAREAN 
GROUP 
 Totally 22 cases (14.6%) were lost to follow up.128 cases returned 
for follow up. 
 Irregular bleeding was major complaint in 4 cases (3.13%). 
 Strings were seen in 104 cases (81.25%). 
 Removal of copper T was done in 3 cases (2.34%).It was done  in 2 
cases  who had similar complaint of bleeding at 3
rd
 month  and 1 
case due to patient’s concern of missing strings though USG 
showed IUCD location in uterus. 
 No cases of infection or failure or expulsions were reported. 
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TABLE 14 
OVERALL FOLLOW UP RESULTS 
 Post Placental Intra 
caesarean 
Expulsion 11 (7.33%) 1 (0.66%) 
Infection - - 
Failure - - 
Irregular Bleeding 8 (5.33%) 12 (8%) 
Strings Seen 115 (76.6%) 104 (69.3%) 
Removal 7 (4.66%) 8 (5.33%) 
 
              p value in expulsion group is 0.003
** 
which is significant. 
              P value in removal group is 0.79 which is not significant. 
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TABLE - 15 
TOTAL EXPULSION RATES 
Follow-up Period Post placental Intra caesarean 
 
6 Weeks 
 
10(6.66%) 
 
1(0.66%) 
 
3 Months 
 
1(0.72%) 
 
0 
 
6 Months 
 
0 
 
0 
 
Total 
 
11(7.33%) 
 
1(0.66%) 
 
Expulsion rates are higher in post placental group when compared 
to intra caesarean group. 
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TABLE 16  
TOTAL REMOVAL RATES 
Follow-up Period Post placental Intra caesarean 
 
6 Weeks 
 
2(1.33%) 
 
0 
 
3 Months 
 
3(2.17%) 
 
5(3.59%) 
 
6 Months 
 
2(1.49%) 
 
3(2.34%) 
 
Total 
 
7(4.66%) 
 
8(5.33%) 
 
Removal rates were 4.66% in post placental group and 5.33% in 
intra caesarean group respectively. 
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TABLE – 17 
LOST TO FOLLOW-UP 
Follow-up 
Period 
Post placental Intra caesarean Total 
 
6 Weeks 
 
0 
 
0 
 
0 
 
3 Months 
 
12 
 
11 
 
23 (7.6%) 
 
6 Months 
 
16 
 
22 
 
38 (12.6%) 
 
Totally 12.6% did not return for follow up. 
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CONTINUATION RATES 
TABLE 18 
                                     Continuation      
Rates 
 
Post placental 
Expulsion      11 
(7.33%) 
    
 132 (88%) 
Removal       7 
 (4.66%) 
 
Intra Caesarean 
Expulsion         1 
(0.66%) 
 
141 (94%) 
Removal         8 
(5.33%) 
 
Continuation rates were 88% in post placental group and 94% in 
intra caesarean group. 
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TOTAL ANTENATAL WOMEN COUNSELLED 
932 
 
 
           Accepted IUCD                                                   Declined IUCD 
             368 (39.4%)                                                         564 (60.51%)                                                            
 
IUCD Inserted         Not Inserted 
362 (98.3%)                6 (1.63%) 
                                          
                                                   150 Post placental 
300 Cases followed-up  
             150 Intra caesarean 
 
Number of Women who returned 
At 6 weeks = 300 (100%) 
 
 
Number of Women who returned 
At 3 months = 277 (92.33%) – 23 cases lost to follow-up (7.6%) 
 
 
Number of Women who returned – 38 Cases lost to follow-up (12.6%) 
At 6 months = 262 (87.3%) 
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DISCUSSION 
        This study is conducted at RSRM Lying in Hospital, to assess the 
acceptance and insertion rates of PPIUCD among antenatal women 
admitted in labour ward and in early labour who were eligible for 
PPIUCD insertion. Total deliveries from January to March 2014  
were 2200. 
         About 932 women were eligible for insertion and hence 
counselling given. 368 antenatal women accepted this method (39.4%) 
and among them 362 were inserted ( 38.8%).The difference in acceptance 
and insertion is because 2 cases had distorted uterine cavity due to fibroid 
during caesarean section and 4 developed PPH after delivery. Gupta et 
al
36
 study shows acceptance rate as 14.4%. 
300 women who had PPIUCD inserted -150 after normal vaginal 
delivery,150 after caesarean section were followed up at 6 weeks,3 
months and 6 months to find the expulsion ,removal and continuation 
rates. The remaining women wanted to have their follow up visit at 
nearby hospital. 
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 Many of earlier studies compared Lippes loop with copper bearing 
IUCD models and found that effectiveness was significantly lower for 
Lippes loop in immediate postplacental insertion
34
.(chi et al 1985). 
In this study majority of those inserted with PPIUCD  belong to 
age group – 21-25 years.53.5% in post placental and 58.5% in intra 
caesarean group. Majority belong to parity 1 (80.11%). 
Majority of them studied up to secondary education. 48.9% in post 
placental and 57.3% in intra caesarean group. 
             The overall expulsion rates were 7.33% in post placental group 
and 0.66% in intra caesarean group at end of 6 months shows a 
significant difference (p=0.003
**)
 .Celen s et al
35
 showed 1 year expulsion 
rate of 12% in immediate PPIUCD insertion .Gupta et al
36
 showed 6 
months expulsion rates as 6.6 % and 2% in both groups. 
Shangai and Rivera et al
37
  showed no significant difference in 
continuation rates when IUCD is inserted manually by hand or forceps. 
Gozmann et al
18
 in 1993 showed expulsion rate of 7-15% at 6 months. 
Morrison et al
38
 reported that age and parity did not affect expulsion 
rates. 
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              In our study, total expulsions occurred in 12 cases. Majority of 
expulsions occurred in parity 2 – 8 cases (66.66%). 
7 cases in post placental at 6 weeks, 1 case in intra caesarean group 
.The expulsion rates were 6.66%,0.34%,at 6 weeks,3 months respectively 
in post placental and 0.79% at 6 weeks in intra caesarean group. 
Expulsion rates gradually reduced from 1
st
 to 6
th
 month. 
           Study of chi et al 1985
34
 and cole 1984 shows that experience of 
the provider may influence expulsion rates. 
            A turkey study
39
 showed rates of complete expulsions as  
                        14% - following insertion < 10 minutes. 
                        19% - 10 minutes to 48 hours insertion. 
                          4%  - IUCD inserted > 6 weeks after delivery. 
          Irregular bleeding occurred in 8 cases (5.33%) in post placental and 
12 cases(8%) in intra caesarean group. The rates at 6 weeks,3 months,6 
months were 1.33%,4%,1.51% and 1.33%,4.66%,2.66% respectively in 
each group. 
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Most patients do not complain bleeding because any bleeding due to 
IUCD will be disguised by lochia - cochrane database .Gupta et al
36
 
showed bleeding rates as 3.33% and 5.33% in both groups. 
         Overall removal rate is 5% (15 cases).Removal was done in 7 cases 
(4.66%) in post placental and 8 cases (5.33%) in intra caesarean group. 
Post placental group-3 cases due to bleeding, 4 cases belong to 
parity 2 willing for interval sterilisation. 
 Intra caesarean group-4 cases due to bleeding, 4 cases belong to 
parity 2   willing for interval sterilisation,1 at patients request due to 
missing string. 
 Irregular bleeding(46.6%) was found to be the major complaint for 
removal. 
Zhou SW et al
40
 (1991) showed removal rates as 4.6%and 4.2% 
respectively in both groups. 
There was no failure or infection or perforation in our study. 
Thiery et al
41
 1985 showed failure rate of 0.85% following post placental 
insertion. 
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Rates of perforation was very low following post placental approximately 
1 in each population with patient ranging from 1150-3800(cole 1984)
42
. 
Roz velarto et al, Zachariar et al
43
 1986 showed lactation was not 
affected by post placental insertion. 
Younis et al 1993 showed that uterine involution is not affected.                              
Threads were visualised in 76.6% in post placental and 69.3% in intra 
caesarean group respectively. Kittur et al 2012
44
 showed copper T to be 
in situ in 94.78% and ultra sonogram done in 24.76% to find its location 
in cases were strings were not visible.      
        16 cases (10.6%) in post placental and 22 cases (14.66%) in intra 
caesarean group did not come for follow up. 
             Overall continuation rates were- 88% vs 94% in both groups 
respectively. In Celen S study
35
, the continuation rates were 81.6% and 
62% at 6 and 12 months, respectively in intra caesarean copper T 
insertion. 
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SUMMARY 
The summary of this study conducted at RSRM Lying in hospital 
in women who were willing for PPIUCD insertion is as follows. Eligible 
women were counselled and recruited on the basis of medical eligibility 
criteria. Women were excluded from the study if they are not willing for 
PPIUCD insertion, had ruptured membranes > 18 hours, maternal fever, 
uterine anomalies , myoma uterus, anaemia and postpartum haemorrhage. 
             Among those who were counselled, 368 accepted for PPUCD 
insertion- the acceptance rate being 39.4%. 
            Among those who accepted actual insertion was done in 362 (2 
had distorted uterine cavity due to myoma uterus,4 had PPH) – actual 
insertion rate being 38.8%.                    
             PPIUCD was inserted after getting an written informed 
consent.300 cases (150 in post placental insertion, 150 in intra caesarean)  
were followed up at 6 weeks,3months and 6 months. 
A detailed history was elicited and thorough general and systemic 
examination was done before PPIUCD insertion and during follow up. 
The results are interpreted by chi- square tests. 
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             In this study majority are in age group 21-25 years.53.5% in post 
placental group and 58.5% in intra caesarean group. 
           Majority of them are educated and belong to secondary 
education.(48.9% in postplacental,57.3% in intra caesarean group) and 
this shows that they accept this method better than those who were not 
educated.(7.57% in postplacental,8.53% in intra caesarean group). There 
were few graduates (6.56% and 8.53% respectively in both groups) 
because majority of antenatal women coming to our hospital belong to 
low socio economic status.  
             80.11% belong to primi parity as majority of multiparous women 
were willing for a permanent method of sterilisation. 
                Total expulsions were in 12 cases - 11(7.33%) cases in post 
placental and 1 case (0.79%) in intra caesarean group.10 cases (6.7%) vs 
1 case (0.7%) in each group respectively had expulsions at 6 weeks 
shows a significant difference with p value of 0.006.expulsions occurred 
mainly in parity 2 - 66.6%.Rates were found to decrease from 6 weeks to 
6 months. 
            Irregular bleeding occurred in 5.33% in post placental and 8% in 
intra caesarean group.  
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            Threads were visualised in 76.6%  in post placental and 69.3% in 
intra caesarean group respectively.        
   Overall removal rate is 5% (15 cases).Removal was done in 7 
cases(4.66%) in post placental and 8 cases(5.33%) in intra caesarean 
group. The major reason for removal due to complication was irregular 
bleeding  in 7 cases(46.6%).7 cases belonging to parity 2 were willing for 
interval sterilisation. 
No cases of infection or failure was noted.16 cases(10.6%) in post 
placental and 22 cases (14.66%) in intra caesarean group did not come 
for follow up. 
Overall continuation rates were- 88% vs 94% in both groups 
respectively. 
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CONCLUSION 
This study was conducted to assess the acceptability of PPIUCD in 
order to address the need for postpartum spacing methods. Acceptance 
was found to be higher in primi parity and in age group 21-25 years. 
Follow up results show that  PPIUCD was demonstrably safe, having no 
reported incidence of  infection, failure, perforation with low rates of 
expulsion, bleeding and lost strings .Though expulsion rates are high in 
post placental group compared to intra caesarean group, the continuation 
rates were high in both groups and thus this method gives a great 
opportunity for postpartum woman to receive a long acting, safe 
contraceptive method before leaving the hospital – a step towards 
diminishing the unmet need of family planning. 
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ANNEXURES 
  
ABBREVIATIONS 
PPIUCD         -       Post partum  intrauterine  contraceptive device 
IUCD             -       Intrauterine contraceptive device 
MOH             -       Ministry of  Health 
JHPEIGO       -       John Hopkins Program for International Education 
in  Gynaecology and  Obstetrics. 
FHI               -         Family Health International 
STD               -        Sexually Transmitted Diseases 
JSY                -        Janani Suraksha Yojana 
PROM           -        Premature rupture of membranes 
USAID          -        United States Agency for International Development 
MEC              -        Medical Eligibility Criteria 
WHO              -       World Health Organisation 
USFDA          -        United States Food and Drug Administration 
ESR  - Erythrocyte Sedimentation rate  
PPH  - Post Partum Haemorrhage  
PROFORMA 
1. Name 
2.  Age 
3. IP NO. 
4. Address with phone number 
5. Education status 
6. Menstrual history            
7. Obstetric  h/o.   
8.PPIUCD – accepted/declined 
7.Obstetrics events  -  Fever 
                                     Anatomic uterine abnormality 
                                     Post partum haemorrhage 
 
8.Consent  for PPIUCD insertion with signature  
 
9. General examination 
 
10.Abdominal examination 
11. Bimanual  pelvic examination followed by insertion 
 
 
12. Time of insertion 
                              -post placental 
                              -intra caesarean 
13. Date of insertion  
14.Follow up schedule                    6wks           3mths       6mths 
 
15.Speculum examination  -  for visualisation of strings 
16.Bimanual pelvic examination if any complaint 
17.At each time of follow up visit 
                           Client satisfaction 
                            Any complaints of 
                                                Irregular bleeding P/V 
                                                Foul smelling vaginal discharge  
                                                Fever 
                                                Expulsion  
                                                Pain 
                                                Missing strings 
                                                Request for removal 
                                                Reason for removal 
                                                Pregnancy 
18.Ultrasonogram when thread not visualised. 
 
 Please return to  Hospital when you develop the following;  
 
 
 
discoloured)  
 
 
 
 
  
தகவல் படிவம் 
 
 ஸ்டான்லி மருத்துவமளனயின் ஆர். எஸ். ஆர். எம். 
மருத்துவமளனயில் மகப்கபறு மற்றும் கபண்கள் நல மருத்துவ 
துளறயில் கமற்ககாள்ளப்படும் ஆய்வு கதாடர்பான தகவல் 
படிவம் இது. 
 இந்த ஆய்வு மரு. ர.    , அவர்களால் அனுபவம் வாய்ந்த 
மருத்துவர்களின் உதவிகயாடு நடத்தப்படுகிறது. 
 இந்த ஆய்வு கருத்தளட சாதனம் (Copper-T)         . 
      ர                        ன     
                   ன            ன       
             ர  ,    ன   ர           
                                        
              . 
 இந்த ஆய்வு கபண்கள் தங்கள் சுயவிருப்பத்துடன் 
முன்வந்தால் மட்டுகம கமற்ககாள்ளப்படும். 
 
ஒப்புதல் படிவம் 
 
திரு. /  திருமதி. ......................................................................................................... 
..........................................................................................................................................
..........................................................................................................................................
.......................................................................................................................................... 
என்ற விலாசத்தில் வசிக்கும் நான், எனக்கு அளிக்கப்பட்ட தகவல் 
படிவத்தில் உள்ள விவரங்களள படித்தும், ககட்டும் புரிந்து 
ககாண்கடன். 
 ஆய்வின் முடிவிளன கசாந்த அளடயாளங்களள 
கவளியிடாமல் மருத்துவ ஆராய்ச்சிக்காக பயன்படுத்திக் ககாள்ள 
சம்மதிக்கிகறன். 
 
 
 
 
 
நாள் : ளககயாப்பம்  
 
இடம் : கபயர் 
 
  
CONSENT FORM 
STUDY TITLE :     “STUDY ON ACCEPTABILITY AND 
FOLLOW UP OF POSTPARTUM 
INTRAUTERINE CONTRACEPTIVE 
DEVICE IN A TERTIARY CARE 
HOSPITAL” 
 
STUDY CENTRE      : R.S.R.M. Lying in Hospital, Stanley Medical College,  
     Chennai. 
 
 
PARTICIPANT NAME :              AGE:   SEX:           J.D.NO. 
 
 I confirm that I have understood the purpose of procedure for the above 
study, I have the opportunity to ask the question and all my questions and doubts 
have been answered to my satisfaction. 
 I understand that the investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in respect 
to the current study and any further research that may be conducted in relation to it, 
even if I withdraw from the study.  I understand that my identity will not be revealed 
in any information released to third parties of published, unless as required under the 
law.  I agree not to restrict the use of any  results that arise from the study. 
 
 
 I hereby consent to participate in this study of  :  
 “STUDY ON ACCEPTABILITY AND FOLLOW 
UP OF POSTPARTUM INTRAUTERINE 
CONTRACEPTIVE DEVICE IN A TERTIARY 
CARE HOSPITAL” 
 
Place :      Signature of Investigator:  
Date  :      Study Investigators Name   
Institution :        Signature / Thumb Impression of patient 
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1 KALPANA 21 55 P1L1 10TH 1.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
2 KAVITHA 20 94 P1L1 12TH 2.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
3 KAMALA 25 97 P1L1 8TH 2.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
4 RAMADEVI 19 28 P1L1 NIL 2.1.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO YES YES YES
5 AARTHI 20 85 P1L1 12TH 3.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
6 BALITHA 20 187 P1L1 10TH 5.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
7 KANIMOZHI 21 182 P1L1 8TH 5.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
8 JOTHI 17 185 P1L1 7TH 6.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
9 KANNAGI 22 200 P2L2 10TH 6.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
10 VETRISELVI 19 107 P1L1 6TH 6.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
11 BAVANI 19 261 P1L1 12TH 7.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
12 NATHIYA 20 295 P1L1 10TH 8.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
13 LAVANYA 20 316 P1L1 10TH 8.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
14 VIJAYA 17 317 P1L1 8TH 8.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
15 MARIYAMMAL 21 365 P2L2 10TH 9.1.14 YES NO NO NO NO NO
16 CHANDRAKALA 20 366 P1L1 12TH 9.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
17 JAYASREE 19 329 P1L1 10TH 10.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
18 LAVANYA 19 384 P1L1 10TH 10.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
19 POORNIMA 18 401 P1L1 NIL 11.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
20 KALEESWARI 20 563 P1L1 BCOM 14.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
21 NIROSHA 26 643 P1L1 B.E 17.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
22 PRINTY 24 607 P2L2 MBA 18.1.14 NO NO NO NO NO NO NO NO NO NO NO YES
23 SHARMILA 21 608 P1L1 12TH 18.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
24 AMUDHA SANDHAIYA 22 725 P1L1 BA 18.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
25 ANJALI 20 728 P1L1 6TH 19.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
26 MALATHY 21 868 P1L1 BSC 22.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
27 SANDIYA 20 845 P1L1 10TH 22.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
28 YUVARANI 18 954 P1L1 10TH 23.1.14 YES NO NO NO NO NO
29 ANISH 21 1165 P1L1 8TH 23.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
30 NIRMALA 20 1116 P1L1 10TH 23.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
31 GAYATHRI 20 1269 P1L1 12TH 23.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
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32 VINISHRI 21 1264 P1L1 BCOM 25.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
33 NAGAVALI 18 1297 P1L1 10TH 26.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
34 KALAISELVI 24 1327 P2L2 12TH 26.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
35 KALPANA 21 1374 P1L1 NIL 27.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
36 GAYATHRI 20 1368 P1L1 10TH 27.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
37 LAVANYA 20 1408 P1L1 6TH 27.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
38 YAMINI 21 1455 P1L1 NIL 30.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
39 KARPAGAM 25 1452 P1L1 5TH 30.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
40 SANGEETHA 29 1447 P2L2 12TH 31.1.14 YES NO NO NO NO NO
41 PREMAKUMARI 20 1481 P1L1 12TH 31.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
42 UMA 21 1505 P1L1 BA 31.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
43 SHOBANA 20 1515 P1L1 9TH 1.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
44 VIJI 19 1547 P1L1 6TH 1.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
45 CHITHRA 21 1628 P1L1 NIL 1.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
46 KALAIVANI 22 1640 P1L1 10TH 1.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
47 DEVIKA 21 1714 P1L1 10TH 2.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
48 RAGINI 21 1757 P2L2 10TH 2.2.14 NO NO NO NO YES NO YES NO NO NO YES NO
49 DIVYA 19 1763 P1L1 10TH 2.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
50 LAKSMI 29 177 P2L2 BBA 3.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
51 SHARMILA 24 1749 P1L1 8TH 3.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
52 GAYATHRI 20 1789 P1L1 6TH 3.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
53 DEIVANAI 20 1799 P1L1 12TH 4.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
54 REKHA 20 1852 P1L1 12TH 4.2.14 NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO NO YES NO
55 RAJATHI 24 1849 P1L1 12TH 4.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
56 SOWMYA 21 1857 P1L1 10TH 4.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
57 NEELI 24 1898 P1L1 NIL 4.2.14 YES NO NO NO YES NO
58 PAVITHRA 21 1899 P1L1 10TH 5.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
59 PONNI 23 1956 P1L1 8TH 5.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
60 DHANALAXMI 21 2019 P2L2 12TH 5.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
61 REVATHI 24 2018 P2L2 8TH 5.2.14 YES NO NO NO NO NO
62 THEJASRI 24 2251 P1L1 12TH 5.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
63 YESODA 21 2124 P1L1 10TH 5.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
64 REVATHY 19 2093 P1L1 12TH 6.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
65 BENAZIR 19 2104 P1L1 10TH 6.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
66 SINDU 19 2099 P1L1 10TH 6.2.14 NO NO NO YES YES NO NO NO NO NO YES NO NO NO NO NO YES NO
67 PRIYA 23 2114 P1L1 12TH 6.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
68 MEENAKSHI 19 2162 P1L1 11TH 6.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
69 SHOBANA 23 2174 P2L2 9TH 6.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
70 YAMUNA 23 2096 P1L1 NIL 7.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
71 DEEPA 25 2175 P1L1 10TH 7.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
72 DEVIKA 26 2161 P2L2 8TH 7.2.14 YES NO NO NO YES NO
73 YASMIN 21 1409 P2L2 8TH 7.2.14 NO NO NO NO YES NO NO NO NO NO YES YES
74 PARIMALA 21 1418 P1L1 10TH 7.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
75 KAVITHA 21 1372 P1L1 12TH 8.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
76 LOGANAYAKI 22 2153 P1L1 12TH 8.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
77 BANUSANKARI 19 2160 P1L1 12TH 8.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
78 SHEELA 22 2270 P1L1 12TH 9.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
79 RESHMA 19 2269 P1L1 12TH 9.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
80 SHEMSATH 21 2286 P1L1 NIL 9.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
81 REVATHY 21 2301 P1L1 7TH 9.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
82 CHITHRA 21 2307 P1L1 12TH 9.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
83 ASYADAS 18 2289 P1L1 9TH 10.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
84 DEIVANAI 19 2833 P1L1 10TH 10.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
85 GNANAPRIYA 21 2347 P1L1 BA 10.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
86 KALYANI 20 2348 P1L1 12TH 10.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
87 MAHALAXMI 30 2353 P2L2 MA 10.2.14 NO NO NO NO NO NO NO NO NO NO YES YES
88 ABIRAMI 24 2140 P2L2 NIL 11.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
89 GEETHA 19 2385 P1L1 6TH 11.2.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO YES YES YES
90 MONISHA 20 2365 P1L1 10TH 12.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
91 PREMAKUMARI 25 2380 P1L1 12TH 12.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
92 NAGAVALI 20 2396 P1L1 10TH 12.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
93 ARCHANA 25 2401 P1L1 12TH 12.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
94 MAHIBU 20 2430 P1L1 9TH 12.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
95 INDUMATHI 19 2467 P1L1 12TH 13.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
96 ANTHONI 19 2476 P1L1 11TH 13.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
97 BABITHA 20 2420 P1L1 5TH 14.2.14 YES NO NO NO NO NO
98 ASWINI 20 2488 P1L1 NIL 14.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
99 MALLIKA 27 2492 P2L2 NIL 14.2.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO NO YES NO
100 SUMITHA 22 2458 P1L1 12TH 14.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
101 KRISNAVENI 23 2491 P1L1 9TH 14.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
102 SIVAGAMI 19 2054 P1L1 8TH 15.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
103 PRIYA 19 2560 P1L1 12TH 15.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
104 INDUMATHI 21 2611 P1L1 12TH 16.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
105 MURUGAVALI 21 2615 P1L1 10TH 18.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
106 MAHALAXMI 21 2568 P1L1 BSC 18.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
107 EPSIBA 21 2612 P1L1 10TH 18.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
108 MAHESWARI 21 2622 P1L1 10TH 18.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
109 DEVI 26 2617 P2L2 8TH 18.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
110 SUBASRE 21 2599 P2L2 8TH 18.2.14 YES NO NO NO NO NO
111 MUTHAMA 21 2138 P1L1 5TH 19.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
112 SANDIYA 19 2657 P1L1 10TH 19.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
113 ANJALI 21 2666 P1L1 7TH 20.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
114 SUMATHI 21 2446 P1L1 NIL 20.2.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO NO YES NO
115 UMA 21 2609 P1L1 8TH 20.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
116 NAVOMI 22 2694 P1L1 5TH 20.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
117 GEETHA 23 2690 P1L1 BA 20.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
118 KOUSALYA 19 2579 P1L1 10TH 21.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
119 MANILA 20 2331 P2L2 10TH 21.2.14 YES NO NO NO NO NO
120 PACHAIMAL 26 2737 P2L2 12TH 22.2.14 NO NO NO NO YES YES
121 SANDIYA 21 2714 P1L1 12TH 23.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
122 SUREKHA 20 2665 P1L1 12TH 25.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
123 KALAIARASI 24 2588 P2L2 8TH 25.2.14 YES NO NO NO NO NO
124 AMSA 23 2750 P1L1 10TH 25.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
125 NAGAMMAL 22 2875 P1L1 7TH 25.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
126 MANJU 20 2833 P1L1 NIL 25.2.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO NO YES NO
127 KANAGA 22 2730 P1L1 NIL 26.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
128 TAMILARASI 19 2856 P1L1 10TH 26.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
129 VANITHA 21 2892 P1L1 10TH 26.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
130 BANUSANKARI 18 2886 P1L1 8TH 27.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
131 PAVITTHRA 19 2915 P1L1 NIL 27.2.14 NO NO NO YES YES YES
132 DANABAGYAM 20 2930 P1L1 6TH 28.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
133 SASIKALA 21 2924 P1L1 11TH 28.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
134 NANDINI 20 3033 P1L1 BCOM 1.3.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
135 KANMANI 24 2981 P2L2 12TH 1.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
136 RANJANI 21 3042 P1L1 7TH 2.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
137 VASANTHI 22 3094 P1L1 8TH 5.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
138 RAJALAXMI 24 3041 P1L1 12TH 5.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
139 SANKARI 19 2985 P1L1 8TH 6.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
140 MOBIN 22 3068 P1L1 10TH 6.3.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
141 PRIYA 19 3143 P1L1 10TH 6.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
142 KAVITHA 22 3149 P1L1 8TH 8.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
143 KOUSALYA 28 3153 P2L2 8TH 9.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
144 HEMAVATHI 21 3161 P1L1 8TH 9.3.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
145 KALPANA 19 3142 P1L1 12TH 9.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
146 SANGEETA 23 2601 P1L1 9TH 9.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
147 LOGESWARI 18 3270 P1L1 12TH 10.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
148 KALAIVANI 25 3265 P1L1 8TH 10.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
149 DIVYA 26 3280 P2L2 7TH 10.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
150 MONISHA 19 2496 P1L1 9TH 12.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
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1 KUPPU 18 59 P1L1 8TH 1.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
2 REVATHI 24 52 P1L1 12TH 1.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
3 MYTHILI 21 8 P1L1 10TH 1.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
4 JAWCHA SULTANI 21 87 P2L2 NIL 1.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
5 KALA 23 78 P1L1 10TH 1.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
6 INDRA 19 55 P1L1 8TH 2.1.14 NO NO NO NO YES NO NO NO NO NO YES YES
7 PRABAVATHY 19 124 P1L1 10TH 2.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
8 RATHY 22 111 P1L1 NIL 2.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
9 SARASATHY 25 320 P1L1 10TH 3.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
10 NABISHA 21 489 P1L1 10TH 3.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
11 GAYATHRI 20 481 P1L1 10TH 3.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
12 REKA 22 57 P2L2 10TH 3.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
13 SHOBANA 20 681 P1L1 BCOM 4.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
14 SUDHA 25 716 P1L1 9TH 4.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
15 MAHESWARI 18 694 P1L1 8TH 4.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
16 PARVEENA 18 811 P1L1 8TH 5.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
17 DEMEEMNISHA 20 775 P1L1 12TH 5.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
18 RAJESWARI 21 785 P1L1 10TH 5.1.14 NO NO NO YES YES NO NO NO NO YES YES YES
19 NIRMALA 23 839 P2L2 10TH 6.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
20 REVATHY 24 1230 P1L1 BSC 7.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
21 BHUVANESHWARI 22 1160 P2L2 10TH 8.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
22 DASHIRBANU 26 1240 P1L1 10TH 9.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
23 DILAIRANI 23 1207 P1L1 10TH 9.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
24 VIJAILAKSHMI 18 1299 P1L1 10TH 9.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
25 SARANYA 21 1365 P1L1 6TH 10.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
26 JABEENA 19 1177 P1L1 12TH 10.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
27 SHOBANA 21 1407 P1L1 10TH 10.1.14 NO NO NO NO NO NO NO NO NO NO NO NO
28 JEBEENA 21 1498 P1L1 8TH 11.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
29 SUGANYA 19 1435 P1L1 8TH 12.1.14 NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES YES YES
30 MUTHULAKSHMI 20 1552 P1L1 8TH 12.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
31 GLORYDIEENAMARY 25 1604 P2L2 BCOM 12.1.14 NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO NO NO NO
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32 TAMILARASI 24 1611 P1L1 10TH 12.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
33 THILAGAVATHY 20 1623 P1L1 7TH 13.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
34 JAYAGOWRI 35 1682 P1L1 9TH 14.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
35 SOWMYA 20 1644 P2L2 12TH 14.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
36 SHEELA 19 1725 P1L1 8TH 14.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
37 BHAVANI 21 1762 P1L1 10TH 14.1.14 NO NO NO NO YES NO
38 SUNITHA 23 1753 P1L1 12TH 15.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
39 RISWANA 20 1785 P1L1 9TH 15.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
40 ILLAMATHI 21 1793 P1L1 7TH 15.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
41 AZHAGURANI 23 1808 P1L1 NIL 15.1.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO YES YES YES
42 INDHUMATHI 28 1700 P1L1 10TH 16.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
43 CHITRA 30 1752 P1L1 6TH 16.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
44 MALATHY 24 1837 P1L1 7TH 17.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
45 SIVAGAMI 30 1841 P1L1 NIL 17.1.14 NO NO NO NO NO NO NO NO NO NO YES NO
46 RESHMA 25 1797 P1L1 NIL 17.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
47 ARIHA 17 1869 P2L2 9TH 17.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
48 DEEPA 22 1863 P1L1 8TH 18.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
49 VALLI 28 1817 P2L2 8TH 18.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO NO
50 JAINABEGUM 21 1816 P1L1 8TH 18.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
51 PRIYA 19 1892 P1L1 10TH 18.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
52 LATHIKA 22 1909 P1L1 NIL 19.1.14 NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO NO NO NO
53 SANGEETHA 21 1972 P2L2 7TH 19.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
54 VIJAMMAL 21 1948 P1L1 12TH 20.1.14 NO NO NO NO NO NO NO NO NO NO YES NO
55 GOMATHI 22 1987 P1L1 NIL 20.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
56 PAVITHARA 21 1989 P1L1 MSC 21.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
57 LATHA 19 1818 P1L1 8TH 21.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
58 MAHALAKSHMI 27 1965 P1L1 NIL 21.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
59 MAHESWARI 32 1981 P1L1 BSC 22.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
60 KALPANA 26 2256 P1L1 10TH 22.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
61 SUGANTHI 27 1993 P1L1 BCOM 22.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
62 ISHWARYA RANI 26 2127 P1L1 NIL 22.1.14 NO NO NO NO YES NO
63 SHEENA 28 2253 P2L2 MSC 23.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
64 STELLA MARY 29 2134 P1L1 5TH 23.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
65 MALA 22 2083 P1L1 12TH 23.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
66 SARATHI 23 2111 P2L2 12TH 24.1.14 NO NO NO NO NO NO
67 SANDHIYA 19 2113 P1L1 12TH 24.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO NO NO
68 ASWINI 20 2186 P2L2 10TH 24.1.14 NO NO NO NO NO NO NO NO NO NO NO YES
69 SANDHAPRIYA 20 2184 P1L1 12TH 25.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
70 SAMUNDEESWARI 21 1981 P1L1 10TH 25.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
71 CHELLI 21 2110 P1L1 12TH 25.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
72 RAMESHWARI 22 2210 P1L1 NIL 26.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
73 REENA 30 2202 P1L1 12TH 26.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
74 PARVEEN 25 2180 P2L2 10TH 27.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
75 JOTHI 22 1836 P1L1 10TH 27.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
76 REKA 22 2283 P1L1 NIL 27.1.14 NO NO NO NO YES NO
77 REVATHI 25 2271 P1L1 10TH 28.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
78 NAGALAKMI 21 2167 P2L2 BCOM 28.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
79 NITHYA 21 2316 P1L1 BA 28.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
80 SANMADHI 21 2342 P1L1 9TH 28.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
81 VADHINI 21 2321 P1L1 NIL 28.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
82 SHAMI 23 2367 P1L1 7TH 29.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
83 JAYANTHI 20 2118 P1L1 7TH 29.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
84 NADHIYA 22 2387 P2L2 12TH 30.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
85 VIJAYLXMI 21 2283 P1L1 5TH 30.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
86 KANAGA 22 2414 P1L1 NIL 30.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
87 DIVYA 20 2416 P1L1 9TH 30.1.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
88 ANITAH 19 2429 P1L1 8TH 31.1.14 NO NO NO NO YES NO
89 SUGUNA 21 2439 P1L1 8TH 31.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
90 RAJESHWARI 21 2441 P2L2 8TH 31.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
91 RIHANNA PARVEEN 21 2443 P1L1 10TH 31.1.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
92 LATHA 20 2392 P1L1 12TH 31.1.14 NO NO NO NO YES NO NO NO NO YES YES NO NO NO NO NO YES NO
93 SUBASHINI 23 2445 P2L2 10TH 31.1.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
94 KALAIVANI 20 2452 P1L1 8TH 1.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
95 VINOTHA 23 2469 P1L1 10TH 1.2.14 NO NO NO NO YES NO NO NO NO NO YES NO
96 PREMA 24 2329 P1L1 8TH 1.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
97 DATCHAYINI 25 2500 P1L1 4TH 2.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
98 LAXMI 22 2563 P1L1 8TH 3.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
99 MUNIYAMMAL 20 2608 P1L1 9TH 3.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
100 KARPAGAVALLI 19 2589 P1L1 10TH 3.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
101 RENUGA 21 2678 P2L2 8TH 3.2.14 YES NO NO NO YES NO
102 CHANDRAKALA 21 2449 P1L1 10TH 3.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
103 SMITHA 22 2733 P1L1 11TH 3.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
104 VANADHI 22 2719 P1L1 12TH 4.2.14 NO NO NO NO YES NO
105 DURGA 21 2736 P1L1 BCOM 4.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
106 KARTHIGA 20 2813 P1L1 12TH 5.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
107 MALII 22 2587 P1L1 BCOM 6.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
108 VIMALA 20 2569 P2L2 10TH 7.2.14 NO NO NO YES YES NO NO NO NO YES YES YES
109 PAVITHRA 20 3874 P1L1 10TH 7.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
110 KASTURI 20 2872 P1L1 10TH 7.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
111 EESWARI 23 2910 P1L1 8TH 7.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
112 GOWRI 20 2247 P2L2 10TH 7.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
113 LATHA RAJNI 24 2974 P1L1 12TH 8.2.14 NO NO NO NO NO NO NO NO NO NO YES NO
114 AASHINI 19 2979 P1L1 NIL 10.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
115 UMA DEVI 26 3123 P1L1 BCOM 11.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
116 MANJULA 22 3158 P2L2 NIL 13.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
117 VAGITHA BEGUM 22 2946 P1L1 12TH 15.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
118 BAVANI 20 3162 P1L1 9TH 15.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
119 MANJU BEGUM 25 3218 P1L1 12TH 15.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
120 SAFI 23 3236 P1L1 8TH 15.2.14 NO NO NO NO YES NO
121 USHA 22 3231 P1L1 10TH 15.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
122 SHAMINI 21 3235 P2L2 8TH 16.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
123 MUTHULAXMI 26 3085 P1L1 8TH 16.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
124 SARANYA 20 3255 P1L1 10TH 17.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO YES YES NO
125 SELVI 25 3124 P1L1 12TH 19.2.14 NO NO NO NO YES NO
126 ANUSHYA 18 3283 P1L1 9TH 19.2.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
127 MALATHY 21 3258 P1L1 10TH 20.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
128 KUMUDHA 22 3296 P2L2 6TH 21.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO
129 ABIRAMI 25 3386 P1L1 8TH 21.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
130 SUGUNA 24 3393 P1L1 5TH 21.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
131 BUVANA 25 3392 P1L1 11TH 22.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
132 NOORI 29 3391 P1L1 8TH 22.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
133 KAVYA 21 3399 P2L2 12TH 23.2.14 NO NO NO NO NO NO NO NO NO NO YES NO
134 REVATHY 26 3402 P1L1 NIL 23.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
135 JAYANTHI 25 3420 P1L1 10TH 24.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
136 REVATHY 23 2958 P1L1 11TH 25.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
137 FATHIMA 21 3334 P2L2 9TH 25.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
138 ROCHEN 23 3092 P2L2 4TH 25.2.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES
139 VENNILA 22 3232 P2L2 BCOM 26.2.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
140 SAMUNDISHWARI 27 3570 P2L2 10TH 26.2.14 NO NO NO NO NO NO NO NO NO NO YES YES
141 SIVA RAJUM 20 3522 P1L1 10TH 1.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
142 LAXMI 23 3571 P1L1 9TH 1.3.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
143 TULASI 23 3641 P1L1 7TH 1.3.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
144 THILAGAVATHY 23 3623 P1L1 10TH 3.3.14 NO NO NO NO YES NO
145 SUGANTHI 26 3689 P1L1 9TH 5.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
146 UDAYAMANI 26 3704 P1L1 7TH 7.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
147 MANISHA 19 3657 P1L1 7TH 8.3.14 NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO NO YES NO
148  PRIYA 19 3584 P1L1 9TH 8.3.14 NO NO NO NO NO NO
149 KAVITHA 26 3763 P1L1 MCOM 8.3.14 NO NO NO NO YES NO NO NO NO NO YES NO NO NO NO NO YES NO
150 VARSHINI 27 3882 P2L2 4TH 10.3.14 NO NO NO NO NO NO NO NO NO NO YES NO NO NO NO NO YES NO
